BioCentury
ARTICLE | Company News

Hegln Pharmaceutical Co. Ltd., Urodynamix deal

December 13, 2010 8:00 AM UTC

Urodynamix completed the previously announced sale of the majority of its assets to Hegln for C$2.1 million ($2.1 million). As part of the final negotiations for the sale, Urodynamix and the Universit...